Sandoz’s Tyruko biosimilar granted FDA approval to treat relapsing MS
The disease-modifying therapy is approved to treat all indications covered by Tysabri
Read More
Author: Jen Brogan
FDA grants ODD to Nexcella’s multiple myeloma treatment
The drug is currently being assessed in a phase 1b/2a clinical trial
Read More
AstraZeneca’s Soliris approved in Japan for paediatric gMG patients
The drug is the first to be approved in Japan to treat children and adolescents with generalised myasthenia gravis
Read More
Pfizer’s maternal RSV vaccine receives FDA approval
The decision allows Abrysvo to be given to those who are 32 to 36 weeks into their pregnancy
Read More
GSK shares promising results from shingles vaccine trial
The varicella zoster virus that causes shingles and chicken pox is typically present in over 90% of adults globally
Read More- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
- FDA approves once‑weekly Sogroya for wider paediatric use
- SolasCure trial shows faster healing with Aurase Wound Gel
